Patent details

301129 Product Name: ofatumumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301129
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2170388
Status:
Withdrawn
Application number:
301129
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

1

Marketing Authorization Number:
67758
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/2021
Marketing Authorization Country:
Switzerland (CH)

2

Marketing Authorization Number:
67757
Marketing Authorization Type:
EEA
Marketing Authorization Date:
01/02/2021
Marketing Authorization Country:
Switzerland (CH)

3

Marketing Authorization Number:
EU/1/21/1532
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/03/2021
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
15/09/2021
First Marketing Authorization date:
01/02/2021
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
16/09/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
18/09/2024
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
15/09/2021
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Agent

1

Name:
ir. H.A. Witmans c.s.
From:
15/09/2021
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
15/09/2021
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
16/09/2021

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
39/24
Publication date:
25/09/2024
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
38/21
Publication date:
22/09/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
19/09/2024 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /7/0/1/5/2/0800725107/docs/301129_11_622930l193.pdf
18/09/2024 SPC Documents Withdrawal SPC 1 PDF /7/0/1/5/2/0800725107/docs/301129_10_supplprotectioncertificate20240918030429224.pdf
28/08/2024 Outgoing Correspondence Letter to applicant 3 PDF /7/0/1/5/2/0800725107/docs/301129_9_619521l173.pdf
22/09/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /7/0/1/5/2/0800725107/docs/301129_7_435919l174.pdf
15/09/2021 SPC Documents Annex SPC 3 PDF /7/0/1/5/2/0800725107/docs/301129_0_supplprotectioncertificate20210916122816990.pdf
15/09/2021 SPC Documents Marketing Authorization SPC 3 PDF /7/0/1/5/2/0800725107/docs/301129_1_supplprotectioncertificate20210916122816712.pdf
15/09/2021 SPC Documents Accompanying letter SPC 2 PDF /7/0/1/5/2/0800725107/docs/301129_2_supplprotectioncertificate20210916122816635.pdf
15/09/2021 SPC Documents Annex SPC 2 PDF /7/0/1/5/2/0800725107/docs/301129_3_supplprotectioncertificate20210916122816856.pdf
15/09/2021 Application Form First filed application form 3 PDF /7/0/1/5/2/0800725107/docs/301129_4_applicationform20210916122816476.pdf
15/09/2021 SPC Documents Summary of the characteristics of the product 16 PDF /7/0/1/5/2/0800725107/docs/301129_5_supplprotectioncertificate20210916122816925.pdf
15/09/2021 SPC Documents Marketing Authorization SPC 3 PDF /7/0/1/5/2/0800725107/docs/301129_6_supplprotectioncertificate20210916122816776.pdf
15/09/2021 SPC Documents Annex SPC 42 PDF /7/0/1/5/2/0800725107/docs/301129_8_supplprotectioncertificate20210916122817061.pdf